Model Number D134801 |
Device Problems
Device Contamination with Body Fluid (2317); Patient Device Interaction Problem (4001)
|
Patient Problems
Stroke/CVA (1770); Thrombosis/Thrombus (4440)
|
Event Date 06/15/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Initial reporter phone: (b)(6).Additional information received indicates that the device is not available for return, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A device history record evaluation was performed for the finished device 30731916l number, and no internal action related to the complaint was found during the review.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
|
Event Description
|
It was reported that a female patient underwent an ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter.The patient suffered a cerebrovascular accident, and a thrombosis was retrieved.Cerebral infarction occurred after the procedure.As a result of thrombus was collected, a thermal coagulation-like char was confirmed.The patient was under follow-up observation.The physician's opinions on the relationship between the event and the product is that char occurred and the causal relationship cannot be ruled out.Additional information was provided.The physician¿s opinion on the cause of this adverse event is that char occurred frequently from (b)(6) 2022 to (b)(6) 2022, and the causal relationship cannot be ruled out.They stopped the use of the product until cause and measures are provided.Intervention provided includes collection of the thrombus and the patient was under follow-up observation.The patient did require extended hospitalization because of the adverse event, but details are unknown.Relevant tests and laboratory data include thrombus collection, and a hot coagulation-like char was confirmed.There was no thrombus attached on the catheter reported.The patient has exhibited neurological symptoms since the procedure was completed as noted in the description.Follow up has been requested regarding statement, ¿the physician¿s opinion on the cause of this adverse event is that char occurred frequently from (b)(6) 2022 to (b)(6) 2022, and the causal relationship cannot be ruled out.They stopped the use of the product until cause and measures are provided.¿ should additional information become available this complaint will be reassessed accordingly.The adverse events were assessed as mdr reportable.Since the event is life threatening and it might result in permanent impairment of a body function or permanent damage to a body structure; or it could require medical or surgical intervention to prevent permanent impairment of a body function or permanent damage to a body structure, it is to be considered serious and mdr-reportable.The thrombus issue was assessed as mdr reportable.
|
|
Manufacturer Narrative
|
Additional information was received on 05-sep-2022 stating no issues were reported related to temperature and flow on the catheter.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|